Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes

@article{Li2014Glypican4II,
  title={Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes},
  author={Ke Li and Xiaohui Xu and Wenjing Hu and Minyan Li and Mengliu Yang and Yaxu Wang and Yong Luo and Xianxiang Zhang and Hua Liu and Ling Li and Gangyi Yang},
  journal={Acta Diabetologica},
  year={2014},
  volume={51},
  pages={981-990}
}
Glypican-4 (GPC-4) has been identified as a novel adipokine capable of enhancing insulin signaling. A significant association between circulating GPC-4 levels and nonalcoholic fatty liver disease and cardiometabolic risk factors has been found in women. The aim of the present study was to investigate the relationship between GPC-4 and insulin resistance in cross-sectional and interventional studies. We measured circulating GPC-4 (determined with ELISA) in subjects with NGT, IGT, and nT2DM… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Similar Papers

Loading similar papers…